[Immunological study of a population of hemophiliacs treated with non-commercial fractions].
We studied lymphocyte subpopulations, serum beta 2 microglobulin, and viral markers in 115 hemophiliacs who are followed and treated at our center. The only clinical or biological anomaly observed is hypergammaglobulinemia. This frequent finding is independent of hemophilia type and of the intensity of substitutive treatment. This group is characterized by the fact that the patients are treated only by locally prepared coagulation fractions, essentially cryoprecipitates for hemophiliacs A, and not containing any derivative of commercial origin. This series is compared to other recent reports, some of which present a high incidence of immunologic anomalies.
D000163:Acquired Immunodeficiency Syndrome / Q000209:etiology; D006467:Hemophilia A / Q000150:complications / Q000276:immunology* / Q000382:microbiology / Q000628:therapy; D006801:Humans; D006942:Hypergammaglobulinemia / Q000150:complications; D008214:Lymphocytes / Q000032:analysis; D065227:Transfusion Reaction; D001613:beta 2-Microglobulin / Q000032:analysis
D001613:beta 2-Microglobulin
Etude immunologique d'une population d'hémophiles traités par des fractions non commerciales.